Back
Amylyx Pharmaceuticals, Inc. 10K Form
Sell
26
AMLX
Amylyx Pharmaceuticals, Inc.
Last Price:
$12.03
Seasonality Move:
-35.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AMLX News And Ratings
See the #1 stock for the next 7 days that we like better than AMLX
AMLX Financial Statistics
Sales & Book Value
| Annual Sales: | $87.4M |
|---|---|
| Cash Flow: | $-30.4M |
| Price / Cash Flow: | 8.66 |
| Annual Sales: | $3.02 |
| Price / Book: | 3.98 |
Profitability
| EPS (TTM): | -1.79970 |
|---|---|
| Net Income (TTM): | $-149.3M |
| Gross Margin: | $-38.2M |
| Return on Equity: | -70.27% |
| Return on Assets: | -61.11% |
Amylyx Pharmaceuticals, Inc. Earnings Forecast
Key Amylyx Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 6 years for AMLX is -43.68%.
-
The Selling, General & Administrative Expenses for AMLX have been equal to 130.86% of Gross Profit Margin.
-
The Research & Development expenses have been 118.09% of Revenue.
-
The Net Earning history of AMLX is -345.36% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 1 years.
Amylyx Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | AMLX |
| Website: | amylyx.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 13.7 |
| Quick Ratio: | 13.34 |
Price-to-Earnings
| Trailing P/E Ratio: | 4.29 |
|---|---|
| Forward P/E Ratio: | 0 |
AMLX Technical Analysis vs Fundamental Analysis
Sell
26
Amylyx Pharmaceuticals, Inc. (AMLX)
is a Sell
Is Amylyx Pharmaceuticals, Inc. a Buy or a Sell?
-
Amylyx Pharmaceuticals, Inc. stock is rated a SellThe current Amylyx Pharmaceuticals, Inc. [AMLX] share price is $12.02. The Score for AMLX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.